Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| TScan Therapeutics, Inc. | 350,000 | reported | 20 Jan 2026 | tx 3+1,370,000 |
| Candel Therapeutics, Inc. | 202,009 | reported | 28 Nov 2023 | tx 7+542,162−20,153 |
| Akebia Therapeutics, Inc. | 45,000 | reported | 28 Feb 2020 | tx 17+502,017−42,359 |
| Alaunos Therapeutics, Inc. | 22,377 | reported | 08 May 2013 | tx 4+375,000−2,623 |
| PharmaFrontiers Corp. | 20,000 | reported | 14 Mar 2023 | tx 6+77,500 |
| GENZYME CORP | 5,005 | reported | 04 Apr 2011 | tx 30+32,920−89,029 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 20 Jan 2026 | GRANT_AWARD | TScan Therapeutics, Inc. | 350,000 | 0.00 USD | deriv |
| 03 Jan 2025 | GRANT_AWARD | TScan Therapeutics, Inc. | 270,000 | 0.00 USD | deriv |
| 01 Feb 2024 | GRANT_AWARD | TScan Therapeutics, Inc. | 750,000 | 0.00 USD | deriv |
| 28 Nov 2023 | TAX_WITHHOLDING | Candel Therapeutics, Inc. | 20,153 | 0.90 USD | |
| 26 Nov 2023 | GRANT_AWARD | Candel Therapeutics, Inc. | 125,717 | 0.00 USD | |
| 28 Apr 2023 | GRANT_AWARD | Candel Therapeutics, Inc. | 90,000 | 0.00 USD | deriv |
| 14 Mar 2023 | GRANT_AWARD | PharmaFrontiers Corp. | 20,000 | 0.00 USD | deriv |
| 09 Dec 2022 | PURCHASE | Candel Therapeutics, Inc. | 2,468 | 1.93 USD | |
| 08 Dec 2022 | PURCHASE | Candel Therapeutics, Inc. | 3,100 | 1.69 USD | first after silence |
| 28 Nov 2022 | GRANT_AWARD | Candel Therapeutics, Inc. | 90,877 | 0.00 USD | |
| 21 Sept 2022 | GRANT_AWARD | Candel Therapeutics, Inc. | 230,000 | 0.00 USD | deriv |
| 14 Jan 2022 | GRANT_AWARD | PharmaFrontiers Corp. | 18,500 | 0.00 USD | deriv |
| 15 Jan 2021 | GRANT_AWARD | PharmaFrontiers Corp. | 15,000 | 0.00 USD | deriv |
| 28 Feb 2020 | GRANT_AWARD | Akebia Therapeutics, Inc. | 30,000 | 0.00 USD | |
| 28 Feb 2020 | SALE | Akebia Therapeutics, Inc. | 6,976 | 8.70 USD | |
| 28 Feb 2020 | GRANT_AWARD | Akebia Therapeutics, Inc. | 45,000 | 0.00 USD | deriv |
| 02 Jan 2020 | GRANT_AWARD | PharmaFrontiers Corp. | 9,000 | 0.00 USD | deriv |
| 11 Apr 2019 | OTHER | Akebia Therapeutics, Inc. | 13,148 | 7.70 USD | |
| 28 Feb 2019 | GRANT_AWARD | Akebia Therapeutics, Inc. | 65,000 | 0.00 USD | |
| 28 Feb 2019 | GRANT_AWARD | Akebia Therapeutics, Inc. | 100,000 | 0.00 USD | deriv |
| 01 Feb 2019 | GRANT_AWARD | PharmaFrontiers Corp. | 6,000 | 0.00 USD | deriv |
| 12 Dec 2018 | TAX_WITHHOLDING | Akebia Therapeutics, Inc. | 22,235 | 8.94 USD | |
| 28 Feb 2018 | GRANT_AWARD | Akebia Therapeutics, Inc. | 19,500 | 0.00 USD | |
| 28 Feb 2018 | GRANT_AWARD | Akebia Therapeutics, Inc. | 27,700 | 0.00 USD | deriv |
| 04 Oct 2017 | GRANT_AWARD | PharmaFrontiers Corp. | 9,000 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 08 Dec 2022.